Nintedanib

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

42 API Suppliers, 17 USDMF, 5 EU WC, 6 KDMF, 12 NDC API, 31 Listed Suppliers

DEVELOPMENTS

13 Drug(s) in Development

13 Drug(s) in Development

INTERMEDIATES

19 Suppliers

19 Suppliers

DOSSIERs // Finished Dosage Formulations

35 Dossiers, 8 FDA Orange Book, 15 Europe, 2 Canada, 4 Australia, 2 South Africa, 4 Listed Dossiers

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 9 Finished Drug Prices

MARKET PLACE

4 APIs, 5 DOSSIERS // FDF

PATENTS

18 US Patents, 4 US Exclusivities

ANALYTICAL SOLUTION(s)

1 Other Ref. Standards

1 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilations & Company Tracker #PharmaFlow, 66 News

Product Search

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

5,132.00

Annual Reports

FDF Market Place

EXCIPIENTS

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

Other Listed Suppliers

SERVICES

Also known as:

Molecular Formula

C₃₁H₃₃N₅O₄

Molecular Weight

539.6 g/mol

InChI Key

XZXHXSATPCNXJR-ZIADKAODSA-N

1 2D Structure

Nintedanib

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate

2.1.2 InChI

InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38)/b29-28-

2.1.3 InChI Key

XZXHXSATPCNXJR-ZIADKAODSA-N

2.1.4 Canonical SMILES

CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5

2.1.5 Isomeric SMILES

CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N/C(=C\3/C4=C(C=C(C=C4)C(=O)OC)NC3=O)/C5=CC=CC=C5

2.2 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₃₁H₃₃N₅O₄
Molecular Weight	539.6 g/mol
XLogP3	3.3
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	8
Exact Mass	539.25325455 g/mol
Monoisotopic Mass	539.25325455 g/mol
Topological Polar Surface Area	94.2 A^2
Heavy Atom Count	40
Formal Charge	0
Complexity	947
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Ofev
Drug Label	OFEV capsules contain nintedanib, a kinase inhibitor [see Mechanism of Action (12.1)]. Nintedanib is presented as the ethanesulfonate salt (esylate), with the chemical name 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[(4-methyl-1-piperazin...
Active Ingredient	Nintedanib
Dosage Form	Capsule
Route	Oral
Strength	150mg; 100mg
Market Status	Prescription
Company	Boehringer Ingelheim

2 of 2
Drug Name	Ofev
Drug Label	OFEV capsules contain nintedanib, a kinase inhibitor [see Mechanism of Action (12.1)]. Nintedanib is presented as the ethanesulfonate salt (esylate), with the chemical name 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[(4-methyl-1-piperazin...
Active Ingredient	Nintedanib
Dosage Form	Capsule
Route	Oral
Strength	150mg; 100mg
Market Status	Prescription
Company	Boehringer Ingelheim